SlideShare a Scribd company logo
1 of 17
Persistent or recurrent
vaginal discharge
Aboubakr Elnashar
Benha University Hospital, Egypt
Aboubakr Elnashar
Causes of persistence or recurrence
I. Wrong diagnosis of the cause
II. Wrong or inadequate treatment
Type
Dose
Duration
III. Persistence of predisposing factors
Aboubakr Elnashar
I. Diagnosis
Causes of vaginal discharge
Non-infective
Physiological: pregnancy, ovulation, s stimulation
Cervical ectopy
Foreign bodies, such as retained tampon
Vulval dermatitis
Non-sexually transmitted infection
Bacterial vaginosis (BV)
Candidal vaginitis (CV)
Sexually transmitted infection
Trichomonal vaginitis (TV)
Chlamydia trachomatis (CT)
Neisseria gonorrhoeae (NG)
Aboubakr Elnashar
1. Symptoms
TVCVBV
Offensivenon offensiveDischarge:
Offensive
fishy smelling
Vulval itching /
irritation
Vulval itching
soreness
DysuriaSuperficial
dyspareunia
Rarely low
abdominal
discomfortAboubakr Elnashar
2. Signs
TVCVBV
Vulval erythemaVulval erythema
Vaginitisfissuring,oedemaAbsence of
vaginitis
70%: frothy
30%: yellow
Curdy (non
offensive)
Discharge:
Thin white
homogenous
coating walls of
vagina and
vestibule
2% “strawberry”
cervix
Satellite skin
lesions
Aboubakr Elnashar
TVCVBV
>4.5<4.5>4.5pH
NoneNonePresentWhiff
test
Leukocytes;
motile
trichomonads
seen in 80%
Leukocytes,
epithelial
cells; yeast,
mycelia or
pseudomycelia
seen in 80%
Clue cells;
rare leukocytes;
lactobacilli
outnumbered by
profuse mixed flora,
including Gram
positivecocci and
coccobacilli
Microsc
opy
3. Tests
Aboubakr Elnashar
Aboubakr Elnashar
II. Treatment
Bacterial vaginosis CDC, 2010
Recommended regimen
Metronidazole (Flagyl)
500 mg orally twice daily for seven days
Alternative regimen
Tinidazole (Fasigyn)
2 g orally for two days or 1 g for five days
Clindamycin
300 mg orally twice daily for seven days
Pregnancy*
Metronidazole
500 mg orally twice daily for seven days
Aboubakr Elnashar
Recurrent BV: European (IUSTI/WHO)Guideline, 2011
Most patients will have recurrences within 3 to 12
months, whatever treatment has been used.
Suppressive regimens
Metronidazole vaginal gel (Metrogel)
weekly for 16 weeks
Aboubakr Elnashar
Vulvovaginal candidiasis, uncomplicated CDC,
2010
Miconazole 4% cream
5 g intravaginally once daily for three days
Miconazole vaginal suppository
100-mg vaginal suppository once daily for seven days
200-mg vaginal suppository once daily for three days
1,200-mg vaginal suppository in a single dose
Nystatin vaginal tablet
100,000-unit vaginal tablet once daily for 14 days
Tioconazole 6.5% ointment
5 g intravaginally in a single dose
Terconazole 0.4% cream
5 g intravaginally once daily for seven days
Terconazole 0.8% cream
5 g intravaginally once daily for three days
Terconazole vaginal suppository
80-mg vaginal suppository once daily for three days
Fluconazole (Diflucan)
150 mg orally in a single dose
Aboubakr Elnashar
Vulvovaginal candidiasis CDC, 2010
Recurrent:
4 or more episodes/Y. Non albicans: 30% of cases.
Culture: confirm diagnosis & to identify non-albicans.
Initial regimen
Any topical agent 7-14 days or
Fluconazole
100, 150, or 200 mg orally once daily every 3rd day
for 3 doses
Maintenance regimen
Fluconazole
100, 150, or 200 mg orally once weekly for 6 months
Aboubakr Elnashar
Non-albicans VVC
1.First line therapy:
Nystatin (Nysert, Mycostatin, Nystan) pessaries once
or twice nightly for 14 d.
2.2nd line:
600 mg boric acid in gelatin capsule vaginally once
daily for 14 d.
3.The final resort:
Amphotericin B (Fungizone) 50 mg supp for 14 d
4. If non-albicans continues to recur,
Maintenance regimen: Nystatin vaginally /w
Aboubakr Elnashar
Trichomoniasis: CDC, 2010
Recommended regimen
Metronidazole
2 g orally in a single dose
Tinidazole
2 g orally in a single dose
Alternative regimen
Metronidazole
500 mg orally twice daily for seven days
Pregnancy*
Metronidazole
2 g orally in a single dose
Aboubakr Elnashar
Persistent / recurrent TV: European (IUSTI/WHO)Guideline, 2011
{re-infection
±drug resistance}
Check
compliance and exclude vomiting of metronidazole.
re-infection from new or untreated partners
1. Repeat course of standard treatment.
Aboubakr Elnashar
2. If this fails:
HVS or empirical treatment with erythromycin or
amoxycillin
{reduce B-haemolytic streptococci before retreating
with metronidazole as some organisms present in
the vagina may interact and reduce effectiveness of
metronidazole}.
3. Metronidazole
2 to 4 g daily for 7-14 days for metronidazole-
resistant strains.
Aboubakr Elnashar
III. Avoiding predisposing factors
TVCVB V
•multiple s
partners,
•other ST
infections
•lack of
barrier
contraceptive
•smoking
•antibiotics
•diet high in refined
sugars
•uncontrolled DM
•Douching
•local irritants,
perfumed products
•tight-fitting
synthetic clothing
•vaginal douching
•smoking,
•IUCD
•new/multiple s partners
•unprotected SI
•higher doses of
spermicide nonoxynol-9
•shower gels, antiseptic
agents and shampoo in
the bath
Aboubakr Elnashar
Thank you
elnashar53@hotmail.com
Aboubakr Elnashar

More Related Content

What's hot

Atrophic vaginitis
Atrophic vaginitisAtrophic vaginitis
Atrophic vaginitis
raj kumar
 

What's hot (20)

Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 
Antepartum fetal assessment
Antepartum fetal assessmentAntepartum fetal assessment
Antepartum fetal assessment
 
Pre eclampsia geet 11
Pre eclampsia geet 11Pre eclampsia geet 11
Pre eclampsia geet 11
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 
Cervical erison
Cervical erisonCervical erison
Cervical erison
 
Hysteroscopy
HysteroscopyHysteroscopy
Hysteroscopy
 
Hysteroscopy
HysteroscopyHysteroscopy
Hysteroscopy
 
antenatal fetal surveillance
antenatal fetal surveillanceantenatal fetal surveillance
antenatal fetal surveillance
 
Vaginal disgarge
Vaginal disgargeVaginal disgarge
Vaginal disgarge
 
vaginitis.pptx
vaginitis.pptxvaginitis.pptx
vaginitis.pptx
 
PREGNANCY OF UNKNOWN LOCATION DR. SHARDA JAIN DR. JYOTI AGARWAL DR. JYOTI BH...
PREGNANCY OF  UNKNOWN LOCATION DR. SHARDA JAIN DR. JYOTI AGARWAL DR. JYOTI BH...PREGNANCY OF  UNKNOWN LOCATION DR. SHARDA JAIN DR. JYOTI AGARWAL DR. JYOTI BH...
PREGNANCY OF UNKNOWN LOCATION DR. SHARDA JAIN DR. JYOTI AGARWAL DR. JYOTI BH...
 
Post Coital Test (PCT): A Panel Discussion
Post Coital Test (PCT): A Panel DiscussionPost Coital Test (PCT): A Panel Discussion
Post Coital Test (PCT): A Panel Discussion
 
Hydrosalpinx
HydrosalpinxHydrosalpinx
Hydrosalpinx
 
vaginal discharge
vaginal dischargevaginal discharge
vaginal discharge
 
Recurrent miscarriage Prof. Aboubakr Elnashar
Recurrent miscarriage  Prof. Aboubakr ElnasharRecurrent miscarriage  Prof. Aboubakr Elnashar
Recurrent miscarriage Prof. Aboubakr Elnashar
 
Tubal patency tests
Tubal patency testsTubal patency tests
Tubal patency tests
 
Atrophic vaginitis
Atrophic vaginitisAtrophic vaginitis
Atrophic vaginitis
 
Laparoscopy in gynecology
Laparoscopy in gynecologyLaparoscopy in gynecology
Laparoscopy in gynecology
 
Male factor infertility
Male factor infertilityMale factor infertility
Male factor infertility
 

Viewers also liked

Altered vaginal discharge (2)
Altered vaginal discharge (2)Altered vaginal discharge (2)
Altered vaginal discharge (2)
Lifecare Centre
 
Foods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएI
Foods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएIFoods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएI
Foods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएI
Herbal Daily
 
19.Infection Of Vaginal
19.Infection Of Vaginal19.Infection Of Vaginal
19.Infection Of Vaginal
Deep Deep
 
Altered vaginal discharge Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare Centre
Altered vaginal discharge  Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare CentreAltered vaginal discharge  Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare Centre
Altered vaginal discharge Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare Centre
Lifecare Centre
 

Viewers also liked (20)

Abnormal vaginal discharge etiopathogenesis
Abnormal vaginal  discharge   etiopathogenesisAbnormal vaginal  discharge   etiopathogenesis
Abnormal vaginal discharge etiopathogenesis
 
Vaginal discharge
Vaginal dischargeVaginal discharge
Vaginal discharge
 
Altered vaginal discharge (2)
Altered vaginal discharge (2)Altered vaginal discharge (2)
Altered vaginal discharge (2)
 
White discharge leucorrhoea
White discharge  leucorrhoeaWhite discharge  leucorrhoea
White discharge leucorrhoea
 
Leukorrhea
LeukorrheaLeukorrhea
Leukorrhea
 
Vaginitis
VaginitisVaginitis
Vaginitis
 
Foods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएI
Foods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएIFoods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएI
Foods to Eat in White Discharge in Hindi Iवाइट डिस्चार्ज में क्या खाएI
 
Vaginitis
VaginitisVaginitis
Vaginitis
 
19.Infection Of Vaginal
19.Infection Of Vaginal19.Infection Of Vaginal
19.Infection Of Vaginal
 
Vaginitis
VaginitisVaginitis
Vaginitis
 
Altered vaginal discharge Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare Centre
Altered vaginal discharge  Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare CentreAltered vaginal discharge  Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare Centre
Altered vaginal discharge Dr. Sharda jain , Dr. Jyoti Bhaskar Lifecare Centre
 
VULVOVAGINITIS
VULVOVAGINITISVULVOVAGINITIS
VULVOVAGINITIS
 
Cervical cancer screening and hpv vaccination
Cervical cancer screening and hpv vaccinationCervical cancer screening and hpv vaccination
Cervical cancer screening and hpv vaccination
 
EVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALES
EVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALESEVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALES
EVALUATION OF VARIOUS CAUSES OF LEUCORRHOEA IN SEXUALLY ACTIVE FEMALES
 
Syndromic management of sti's
Syndromic management of sti'sSyndromic management of sti's
Syndromic management of sti's
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
 
Emerging treatment of endometriosis
Emerging treatment of endometriosisEmerging treatment of endometriosis
Emerging treatment of endometriosis
 
Subtle Endometriosis
Subtle EndometriosisSubtle Endometriosis
Subtle Endometriosis
 
TRANSDERMAL HORMONAL CONTRACEPTION Prof. Aboubakr Elnashar
TRANSDERMAL HORMONAL CONTRACEPTION Prof. Aboubakr ElnasharTRANSDERMAL HORMONAL CONTRACEPTION Prof. Aboubakr Elnashar
TRANSDERMAL HORMONAL CONTRACEPTION Prof. Aboubakr Elnashar
 
H1 N1 virus infection and pregnancy
H1 N1 virus infection and pregnancyH1 N1 virus infection and pregnancy
H1 N1 virus infection and pregnancy
 

Similar to Persistent or recurrent vaginal discharge

Vulvovaginal Infections,Vaginitis,Fmdrl3
Vulvovaginal Infections,Vaginitis,Fmdrl3Vulvovaginal Infections,Vaginitis,Fmdrl3
Vulvovaginal Infections,Vaginitis,Fmdrl3
MedicineAndHealthUSA
 
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
Ramayya Pramila
 
Pelvic inflammatory disease
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory disease
mediwaves
 

Similar to Persistent or recurrent vaginal discharge (20)

Vulvovaginal Infections,Vaginitis,Fmdrl3
Vulvovaginal Infections,Vaginitis,Fmdrl3Vulvovaginal Infections,Vaginitis,Fmdrl3
Vulvovaginal Infections,Vaginitis,Fmdrl3
 
Recurrent vulvovaginal Candidiasis
Recurrent vulvovaginal CandidiasisRecurrent vulvovaginal Candidiasis
Recurrent vulvovaginal Candidiasis
 
Vulvovaginal candidiasis
Vulvovaginal  candidiasisVulvovaginal  candidiasis
Vulvovaginal candidiasis
 
Urinary Tract Infections
Urinary Tract InfectionsUrinary Tract Infections
Urinary Tract Infections
 
Urinary Tract I nfection.pptx
Urinary Tract I nfection.pptxUrinary Tract I nfection.pptx
Urinary Tract I nfection.pptx
 
Lower genital tract infection
Lower genital tract infectionLower genital tract infection
Lower genital tract infection
 
PUERPERAL SEPSIS & UTI.ppt
PUERPERAL SEPSIS & UTI.pptPUERPERAL SEPSIS & UTI.ppt
PUERPERAL SEPSIS & UTI.ppt
 
Urinary tract infections during pregnancy
Urinary tract infections during pregnancyUrinary tract infections during pregnancy
Urinary tract infections during pregnancy
 
Gyn Infections
Gyn  InfectionsGyn  Infections
Gyn Infections
 
GENITAL TRACT INFECTIONS.pptx
GENITAL  TRACT INFECTIONS.pptxGENITAL  TRACT INFECTIONS.pptx
GENITAL TRACT INFECTIONS.pptx
 
GENITAL TRACT INFECTIONS.pptx
GENITAL  TRACT INFECTIONS.pptxGENITAL  TRACT INFECTIONS.pptx
GENITAL TRACT INFECTIONS.pptx
 
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
Management of Urinary Tract Infections (UTI) in Females (New Born to Elderly)
 
Recurrent pv discharge
Recurrent pv dischargeRecurrent pv discharge
Recurrent pv discharge
 
Mo's vaginitis
Mo's vaginitisMo's vaginitis
Mo's vaginitis
 
Infections of the genital tract мазепкина
Infections of the genital tract мазепкинаInfections of the genital tract мазепкина
Infections of the genital tract мазепкина
 
Bacterial vaginosis
Bacterial vaginosisBacterial vaginosis
Bacterial vaginosis
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
 
22420_VAGINAL DISCHARGE.ppt
22420_VAGINAL DISCHARGE.ppt22420_VAGINAL DISCHARGE.ppt
22420_VAGINAL DISCHARGE.ppt
 
UTIs in pregnancy
UTIs in pregnancyUTIs in pregnancy
UTIs in pregnancy
 
Pelvic inflammatory disease
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory disease
 

More from Aboubakr Elnashar

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Recently uploaded

Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfUnveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
NoorulainMehmood1
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
AarishRathnam1
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 

Recently uploaded (20)

ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
 
Top 15 Sexiest Pakistani Pornstars with Images & Videos
Top 15 Sexiest Pakistani Pornstars with Images & VideosTop 15 Sexiest Pakistani Pornstars with Images & Videos
Top 15 Sexiest Pakistani Pornstars with Images & Videos
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdf
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseases
 
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfUnveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 

Persistent or recurrent vaginal discharge

  • 1. Persistent or recurrent vaginal discharge Aboubakr Elnashar Benha University Hospital, Egypt Aboubakr Elnashar
  • 2. Causes of persistence or recurrence I. Wrong diagnosis of the cause II. Wrong or inadequate treatment Type Dose Duration III. Persistence of predisposing factors Aboubakr Elnashar
  • 3. I. Diagnosis Causes of vaginal discharge Non-infective Physiological: pregnancy, ovulation, s stimulation Cervical ectopy Foreign bodies, such as retained tampon Vulval dermatitis Non-sexually transmitted infection Bacterial vaginosis (BV) Candidal vaginitis (CV) Sexually transmitted infection Trichomonal vaginitis (TV) Chlamydia trachomatis (CT) Neisseria gonorrhoeae (NG) Aboubakr Elnashar
  • 4. 1. Symptoms TVCVBV Offensivenon offensiveDischarge: Offensive fishy smelling Vulval itching / irritation Vulval itching soreness DysuriaSuperficial dyspareunia Rarely low abdominal discomfortAboubakr Elnashar
  • 5. 2. Signs TVCVBV Vulval erythemaVulval erythema Vaginitisfissuring,oedemaAbsence of vaginitis 70%: frothy 30%: yellow Curdy (non offensive) Discharge: Thin white homogenous coating walls of vagina and vestibule 2% “strawberry” cervix Satellite skin lesions Aboubakr Elnashar
  • 6. TVCVBV >4.5<4.5>4.5pH NoneNonePresentWhiff test Leukocytes; motile trichomonads seen in 80% Leukocytes, epithelial cells; yeast, mycelia or pseudomycelia seen in 80% Clue cells; rare leukocytes; lactobacilli outnumbered by profuse mixed flora, including Gram positivecocci and coccobacilli Microsc opy 3. Tests Aboubakr Elnashar
  • 8. II. Treatment Bacterial vaginosis CDC, 2010 Recommended regimen Metronidazole (Flagyl) 500 mg orally twice daily for seven days Alternative regimen Tinidazole (Fasigyn) 2 g orally for two days or 1 g for five days Clindamycin 300 mg orally twice daily for seven days Pregnancy* Metronidazole 500 mg orally twice daily for seven days Aboubakr Elnashar
  • 9. Recurrent BV: European (IUSTI/WHO)Guideline, 2011 Most patients will have recurrences within 3 to 12 months, whatever treatment has been used. Suppressive regimens Metronidazole vaginal gel (Metrogel) weekly for 16 weeks Aboubakr Elnashar
  • 10. Vulvovaginal candidiasis, uncomplicated CDC, 2010 Miconazole 4% cream 5 g intravaginally once daily for three days Miconazole vaginal suppository 100-mg vaginal suppository once daily for seven days 200-mg vaginal suppository once daily for three days 1,200-mg vaginal suppository in a single dose Nystatin vaginal tablet 100,000-unit vaginal tablet once daily for 14 days Tioconazole 6.5% ointment 5 g intravaginally in a single dose Terconazole 0.4% cream 5 g intravaginally once daily for seven days Terconazole 0.8% cream 5 g intravaginally once daily for three days Terconazole vaginal suppository 80-mg vaginal suppository once daily for three days Fluconazole (Diflucan) 150 mg orally in a single dose Aboubakr Elnashar
  • 11. Vulvovaginal candidiasis CDC, 2010 Recurrent: 4 or more episodes/Y. Non albicans: 30% of cases. Culture: confirm diagnosis & to identify non-albicans. Initial regimen Any topical agent 7-14 days or Fluconazole 100, 150, or 200 mg orally once daily every 3rd day for 3 doses Maintenance regimen Fluconazole 100, 150, or 200 mg orally once weekly for 6 months Aboubakr Elnashar
  • 12. Non-albicans VVC 1.First line therapy: Nystatin (Nysert, Mycostatin, Nystan) pessaries once or twice nightly for 14 d. 2.2nd line: 600 mg boric acid in gelatin capsule vaginally once daily for 14 d. 3.The final resort: Amphotericin B (Fungizone) 50 mg supp for 14 d 4. If non-albicans continues to recur, Maintenance regimen: Nystatin vaginally /w Aboubakr Elnashar
  • 13. Trichomoniasis: CDC, 2010 Recommended regimen Metronidazole 2 g orally in a single dose Tinidazole 2 g orally in a single dose Alternative regimen Metronidazole 500 mg orally twice daily for seven days Pregnancy* Metronidazole 2 g orally in a single dose Aboubakr Elnashar
  • 14. Persistent / recurrent TV: European (IUSTI/WHO)Guideline, 2011 {re-infection ±drug resistance} Check compliance and exclude vomiting of metronidazole. re-infection from new or untreated partners 1. Repeat course of standard treatment. Aboubakr Elnashar
  • 15. 2. If this fails: HVS or empirical treatment with erythromycin or amoxycillin {reduce B-haemolytic streptococci before retreating with metronidazole as some organisms present in the vagina may interact and reduce effectiveness of metronidazole}. 3. Metronidazole 2 to 4 g daily for 7-14 days for metronidazole- resistant strains. Aboubakr Elnashar
  • 16. III. Avoiding predisposing factors TVCVB V •multiple s partners, •other ST infections •lack of barrier contraceptive •smoking •antibiotics •diet high in refined sugars •uncontrolled DM •Douching •local irritants, perfumed products •tight-fitting synthetic clothing •vaginal douching •smoking, •IUCD •new/multiple s partners •unprotected SI •higher doses of spermicide nonoxynol-9 •shower gels, antiseptic agents and shampoo in the bath Aboubakr Elnashar